Asset Details
Do you wish to reserve the book?
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA
Do you wish to request the book?
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA
2020
Overview
A trial involving 11,016 patients showed that the combination of ticagrelor and aspirin after a stroke or high-risk transient ischemic attack was better than aspirin alone in preventing a stroke or death within 30 days. Severe bleeding was rare but occurred more frequently in the dual antiplatelet group.
Publisher
Massachusetts Medical Society
Subject
/ Aspirin
/ Bleeding
/ Death
/ Design
/ Female
/ Hemorrhage - chemically induced
/ Humans
/ Ischemia
/ Ischemic Attack, Transient - complications
/ Ischemic Attack, Transient - drug therapy
/ Male
/ Patients
/ Platelet Aggregation Inhibitors - adverse effects
/ Platelet Aggregation Inhibitors - therapeutic use
/ Purinergic P2Y Receptor Antagonists - therapeutic use
/ Stroke
/ Stroke - prevention & control
/ Ticagrelor - adverse effects
